Empagliflozin ameliorates endothelial dysfunction and suppresses atherogenesis in diabetic apolipoprotein E-deficient mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Empagliflozin ameliorates endothelial dysfunction and suppresses atherogenesis in diabetic apolipoprotein E-deficient mice

Published:2020-05 Issue: Volume:875 Page:173040
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Ganbaatar Byambasuren,Fukuda Daiju,Shinohara Masakazu,Yagi Shusuke,Kusunose Kenya,Yamada Hirotsugu,Soeki Takeshi,Hirata Ken-ichi,Sata Masataka

Funder

Boehringer Ingelheim, Japan

JSPS Kakenhi

SENSHIN Medical Research Foundation

Takeda Science Foundation

Vehicle Racing Commemorative Foundation

Publisher

Elsevier BV

Subject

Pharmacology

Reference55 articles.

1. SGLT2 inhibition reduces atherosclerosis by enhancing lipoprotein clearance in Ldlr(-/-) type 1 diabetic mice;Al-Sharea;Atherosclerosis,2018

2. Up-regulation of vascular cyclooxygenase-2 in diabetes mellitus;Bagi;Pharmacol. Rep.,2006

3. Mechanism of increased LDL (Low-Density Lipoprotein) and decreased triglycerides with SGLT2 (Sodium-Glucose Cotransporter 2) inhibition;Basu;Arterioscler. Thromb. Vasc. Biol.,2018

4. Exercise effects on perivascular adipose tissue: endocrine and paracrine determinants of vascular function;Boa;Br. J. Pharmacol.,2017

5. SGLT2 inhibition--a novel strategy for diabetes treatment;Chao;Nat. Rev. Drug Discov.,2010

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Updates in Coronary Artery Disease: A Comprehensive Review;Journal of Clinical Medicine;2024-08-06

2. Longitudinal assessment of coronary plaque regression related to sodium–glucose cotransporter-2 inhibitor using coronary computed tomography angiography;Cardiovascular Diabetology;2024-07-22

3. Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors and Cardiovascular Outcomes: A Review of Literature;Cureus;2024-07-04

4. Endothelial Protection by Sodium-Glucose Cotransporter 2 Inhibitors: A Literature Review of In Vitro and In Vivo Studies;International Journal of Molecular Sciences;2024-07-02

5. The current landscape for diabetes treatment: Preventing diabetes-associated CV risk;Atherosclerosis;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3